Back to results
US 12,102,710 B2Granted
Probiotic skin formulations
AssigneeCrown Laboratories, Inc.
InventorsThomas M. Hitchcock, Sasima Phadungpojna, Matthew D. Stephens, Mun Su Rhee
Life of this patent
Estimating the term…
Abstract
Described herein are dermatological compositions, formulations containing wild type or genetically modified Cutibacterium bacteria and methods for use thereof of skin. The cosmetic and therapeutic formulations described herein can be used as cosmetic daily skin treatments or for treating skin inflammation or disorders including acne, psoriasis, rosacea, dermatitis, or eczema.
Claims2
A dermatological composition consisting of:
- an anhydrous formulation of:
- about 0.1% to about 5% by mass of a dry growth-arrested genetically modified strain of Cutibacterium acnes (C. acnes) that remains in a dormant state for at least six months and up to about 2 years;
- about 55% to about 95% by mass of one or more anhydrous emollients comprising ethyl olivate or Olea europaea leaf extract;
- and
- about 1% to about 15% by mass of one or more anhydrous gelling agents comprising Polyamide-3.
2 more elements
A dermatological composition consisting of:
- an anhydrous formulation of:
- about 0.1% to about 5% by mass of a dry wild-type or growth-arrested genetically modified strain of Cutibacterium acnes (C. acnes) that remains in a dormant state for at least six months and up to about 2 years;
- about 55% to about 95% by mass of one or more anhydrous emollients comprising ethyl olivate or Olea europaea leaf extract;
- and
- about 1% to about 15% by mass of one or more anhydrous gelling agents comprising Polyamide-3.
2 more elements
Dependencies are inferred from the claim text.